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AceEThe analysis of protein–protein interactions inMycobacterium tuberculosis has the potential to shed light on the
functions of the large number of predicted open-reading frames annotated as conserved hypothetical proteins.
We have developed a formaldehyde crosslinking system to detect in vivo interactions in mycobacteria. Our
Gateway-adapted vector system uses three promoter strengths, including constitutive and regulatable versions,
for the expression of target proteins with either an N- or C-terminal His–Strep–Strep tag. Tandem afﬁnity puriﬁ-
cation using theHis- and Strep-tags iswell-suited to the isolation of protein complexeswith a high purity and no
detectable background. We have validated this approach using the well-described pyruvate dehydrogenase
complex.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Mycobacterium tuberculosis (Mtb) remains a serious threat to global
health, with latent infections representing a huge burden of potentially
infectious bacteria. An improved understanding of the molecular basis
of its unique ability to survive long periods of non-growth in the
human host is one of the key challenges in the post-genomic era.
However, a gene function is so far undescribed for a large number of
the predicted Mtb ORFs (Cole et al., 1998). Our past experience in
using genetic approaches to investigate the function of conserved hypo-
thetical proteins has proven ill-suited in certain cases (Hingley-Wilson
et al., 2010), likely due to the large degree of redundancy presentwithin
vitalMtb pathways.
A number of techniques are available for studying protein interac-
tions in mycobacteria, such as the Split-Trp (O'Hare et al., 2008) and
mycobacterial protein fragment complementation (M-PFC) system
(Singh et al., 2006). While the M-PFC system has been used to screen
for interactions with a bait protein through the use of library of prey
plasmids, this is labor-intensive and relies on the expression of both
bait and prey with a large N- or C-terminal tag which is not suitable
for all proteins. Two-hybrid systems are also prone to high numbers of
false positive interactions (Battesti and Bouveret, 2012).
The use of tandem afﬁnity puriﬁcation (TAP) tags can allow proteins
to be expressed in vivo and puriﬁed with their associated partners.Sir Alexander Fleming Building,
m. Tel.:+44 207 594 5383; fax:
liams).
. This is an open access article underHowever, this has a disadvantage in that non-speciﬁc interactions are
often detected and weak or transient interactions can be missed. Form-
aldehyde crosslinking has therefore been previously used to ﬁx interac-
tions prior to more stringent puriﬁcation methodologies that yield
highly-pure protein complexes (Herzberg et al., 2007). Formaldehyde
is capable of penetrating the unusually impermeable mycobacterial
cell wall and crosslinks proteins within around 2 Å of each other. One
potential disadvantage in the sensitivity of this method is that high-
level expression of proteins under non-native conditions could lead to
the identiﬁcation of biologically irrelevant interactions. In addition,
some proteins are toxic when expressed at high levels. Therefore, it is
desirable to be able to vary expression levels to better reproduce the
in vivo conditions under which natural protein–protein interactions
occur. Here we report the construction of a series of Gateway-adapted
vectors for the expression of tagged proteins in mycobacteria for use
in formaldehyde crosslinking procedures to identify protein–protein
interactions in mycobacteria.2. Materials and methods
2.1. Bacterial strains and growth conditions
For in vivo protein cross-linking experiments we usedMycobacteri-
um smegmatis groEL1ΔC (Noens et al., 2011), which was transformed
with the appropriate plasmids and grown in LB medium (5 g yeast
extract, 5 g NaCl, 10 g Tryptone per liter) with continuous shaking
(150 rpm) at 37 °C. 0.05% (v/v) Tween 80 was added to LB to avoid
clumping.the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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tein expression in mycobacteria
Complementary 108 base pair oligonucleotides containing two
Strep-II tags separated and ﬂanked by ﬂexible glycine linkers (GGCA
GCGCCGCGAGCTGGAGCCACCCGCAGTTCGAGAAGGG CGGTGGCAGCGG
CGGTGGCAGCGGCGGTAGCTGGAGCCACCCGCAGTTCGAGAAGGGCAG
CGCCGCG) were annealed by heating to 95 °C and cooling slowly to
room temperature in the heat block. The annealed oligonucleotides
were used as a PCR template to construct the ﬁnal tags. Primers were
designed to amplify the Strep-II tags with the addition of a His-tag, a ri-
bosome binding site and a C- or N-terminal ScaI restriction site
(Cterm_F: TTAATTAACCGGAGGAATCACTTCGCAATGGGCCGGCGAAGT
ACTGGGCAGC GCCGCGAGCTGGAGC, Cterm_R: CGTACGATCGATTCAA
TGGTGGTGGTGGTGGTGCGCG GCGCTGCCCTTCTCGAA, Nterm_F: TTAA
TTAACCGGAGGAATCACTTCGCAATGGGCCGG CGACACCACCACCACCAC
CATGGCAGCGCCGCGAGCTGGAGC, Nterm_R: CGTACGATCG ATTCACAG
TACTCGCGGCGCTGCCCTTCTCGAA). The PCR products were cloned
into pTETR2 via the PacI and BsiWI sites. pTETR2 is an integrating vector
containing a strong mycobacterial promoter into which tet operator
sequences have been inserted along with a tetR gene encoding a repres-
sor which binds the operator sequences and occludes ribosome binding
in the absence of anhydrotetracycline (Schuessler et al., 2013). The
vectors were then Gateway adapted via the ScaI site using the RfC.1
fragment (Gateway Vector Conversion System, Invitrogen), producing
pTIG-N and pTIG-C. The inserts were subcloned into pMV762, aFig. 1. Expression vector construction. (A) Sequence information for the expression plasmids. p
way insertion site by a ﬂexible glycine-rich linker. pHEH-C, pSIG-C, and pTIG-C are C-terminal v
the Strep-II tag sequence plus glycine linkers and PCR used to introduce a ribosome binding sit
Western blotting.M. smegmatis expressing the control protein Rv1636 (15 kDa) from the six ex
anhydrotetracycline (ATc) concentrations from 0 to 100 ng/ml for the pTIG vectors. The upper a
tively. Cells were lysed, and expression of the tagged proteins detected by Western blotting.hygromycin resistant episomal plasmid containing the hsp60 promoter
based onpMV261 (Stover et al., 1991), to produce pHEH-N andpHEH-C,
and into an integrating vector containing an intermediate synthetic pro-
moter to produce pSIG-N and pSIG-C. Sequence information for the
plasmids and plasmid schematics is shown in Fig. 1 and Fig. 2.
2.3. Formaldehyde crosslinking and puriﬁcation of protein complexes
We ﬁrst optimized the concentration of formaldehyde and the incu-
bation time required to induce sufﬁcient crosslinking while minimizing
non-speciﬁc complex formation. A range of concentrations from 0.2 to
2% formaldehyde were added to cultures and incubated for 10 and
20minwith gentle shaking. The formaldehydewas quenched by the ad-
dition of 1/10 culture volume of ice cold glycine in PBS (0.125 M ﬁnal
glycine concentration). Cell lysates were prepared by vortexing for
2 min with an equal volume of 0.2 μm glass beads. To prepare the pro-
teins for separation by SDS-PAGE without reversing the formaldehyde
crosslinking, the lysates were heated at 65 °C for 20 min as described
in Klockenbusch and Kast (2010). Following SDS-PAGE, the complexes
were visualized by Western blotting with an HRP-conjugated penta-
His antibody (Qiagen) to identify the lowest concentration of formalde-
hyde that led to a shift of the AceE band to a higher molecular weight,
indicating that it was found in complexes rather than as a monomer.
Following establishment of an optimized protocol, M. smegmatis was
grown in 2 L of LB-Tween 80 medium until stationary phase when the
culture was used for in vivo crosslinking experiments. FormaldehydeHEH-N, pSIG-N and pTIG-N contain an N-terminal His–Strep–Strep tag linked to the Gate-
ersions of these same vectors. Complementary oligonucleotides were annealed to produce
e, his-tag and restriction sites. (B) Expression from the crosslinking vectors determined by
pression vectors was grown in LB+ 0.05% Tween 80 for 24 h, in the presence of a range of
nd lower panels show expression fromN-terminal and C-terminal tagging vectors respec-
Fig. 2. Schematics of the six Gateway adapted vectors constructed and described in this study.
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at room temperature for 10 min before quenching with PBS–glycine.
The culture was harvested at 10,000 ×g for 10 min, the pellets washed
once in PBS, then resuspended in 20 ml 50 mM Tris–HCl (pH8) and
150 mM NaCl. The cells were incubated at room temperature for
20 min with 2.4 mg/ml lysozyme then sonicated at 40% amplitude on
ice for 10 min, with a 2 second pulse followed by a 2 second pause.
The Strep/His-tagged complexes were puriﬁed using a two-step proce-
dure of StrepTactin FPLC followed by nickel afﬁnity puriﬁcation. Lysates
were cleared by centrifugation at 14,000 ×g for 45 min, loaded onto a
StrepTactin column and washed with 50 mM Tris–HCl (pH8) and
150 mM NaCl until the baseline UV absorption reading returned to
zero. The proteins were eluted with 2.5 mM desthiobiotin, with a
1 hour pause used to release tightly binding complexes. Pooled fractions
were loaded onto a nickel-afﬁnity column in the presence of 40mM im-
idazole andwashed at 100mM imidazole in 50mMTris–HCl (pH8) and
150 mM NaCl to remove any non-speciﬁc contamination. Complexes
were eluted with 500mM imidazole and pooled fractions concentrated
using an Amicon 15 kDa cut-off centrifugation device.
2.4. In gel tryptic digestion
The crosslinking of the puriﬁed complexes was reversed by boiling
in Laemmli buffer for 20 min and the proteins separated by SDS-PAGE.
After running the proteins on an SDS PAGE gel, staining with Imperial
Blue (Thermo) and destaining, bands were cut out of the gel and
added to 0.5 ml silated microfuge tubes. 200 μl 50 mM ammonium
bicarbonate pH 8.4 was added followed by 200 μl of acetonitrile and in-
cubated at room temperature for 5 min. The supernatant was removed
and the process repeated until no further color remained in the gel
pieces, and the gel pieces dried in a SpeedVac for 15 min. The reduction
and carboxymethylation of the proteins were achieved by adding 20 μl
10 mM DTT solution and incubating for 60 min at 57 °C. The DTT was
removed and the gel pieces rinsed brieﬂy with acetonitrile, 20 μl
55 mM iodoacetamide solution added, and incubated for 30–45 min in
the dark at room temperature. The iodoacetamide solution was
removed and the gel pieces washed with 500 μl of 50 mM ammonium
bicarbonate pH 8.4 for 15min, whichwas then removed and 200 μl ace-
tonitrile added for 5 min. The gel pieces were dried by washing twice
with 200 μl acetonitrile and the acetonitrile removed. For tryptic
digestion, 20 μl trypsin solution was added to gel pieces and incubated
for 15–20 min at room temperature and then further ammoniumbicarbonate solution was added to cover the gel pieces, if needed, and
incubated at 37 °C overnight. To elute the peptides from the gel pieces,
the peptide solution was removed into a clean silated tube. The gel
pieces were washed with 50% acetonitrile, adding sufﬁcient to cover
the gel pieces and incubated at 37 °C for 15 min. This wash was added
to the saved supernatant, the volume reduced to 1–2 μl in a SpeedVac,
30 μl 1% acetonitrile added and acidiﬁed with 0.1% formic acid, and the
sample frozen−20 °C. Prior to MS the sample was spun at 10,000 ×g
for 10 min and the supernatant removed for MS.
2.5. Peptide analysis using high pressure liquid chromatography and mass
spectrometry
Samples were loaded on a Zorbax SB-C18 5µm, 35 x 0.5 mm
(Agilent) trap column and washed for 60 min using 96.7% water: 3%
acetonitrile: 0.3% formic acid; the extended wash was to remove resid-
ual KCl remaining from the ion exchange puriﬁcation step. Peptides
were separated using a Zorbax 300SB-C18 5µm, 150 x 0.3 mm capillary
column (Agilent) at a ﬂow rate of 5 ml/min using an Agilent 1100 HPLC
system. Buffer C (94.9% water: 5% acetonitrile: 0.1% formic acid) and
Buffer D (94.9% acetonitrile: 5% water: 0.1% formic acid) were used for
the elution of peptides according to the following program: gradient
0–30% Buffer D over 90 min, gradient 30–90% Buffer D over 10 min,
90% Buffer D for 10 min, gradient 90–100% Buffer D over 1 min and
100% Buffer D for 10 min. Eluted peptides were analyzed using a Q-
TRAP mass spectrometer (Applied Biosystems) equipped with a Turbo
Spray Ion source at 150 μC. Data were collected with an IDA method
consisting of a survey scan (350m/z to 1200 m/z), an enhanced resolu-
tion scan and four enhanced product ion scans. Dynamic background
subtraction was used prior to ion selection; the four most abundant
doubly or triply charged ions were selected for the product ion scans.
The resulting spectra were analyzed and quantiﬁed using ProteinPilot
software (Applied Biosystems), quoted signiﬁcance valueswere obtain-
ed with the inbuilt statistical analysis tool.
3. Results and discussion
The analysis of protein–protein interactions in mycobacteria has the
potential to shed light on the functions of the large number of predicted
open-reading frames annotated as conserved hypothetical proteins.We
have developed a formaldehyde crosslinking system to detect in vivo in-
teractions in mycobacteria.
Fig. 3. AceE interacting proteins. M. smegmatis containing pTIG-N::aceE grown in LB +
0.05% Tween 80 was induced with 100 ng/ml ATc for 24 h and complexes crosslinked
with 0.4% formaldehyde. The Strep/His-tagged complexes were puriﬁed as described in
the Materials and Methods section, crosslinks were reversed by heating at 95 °C for 20
min and the proteins separated by SDS-PAGE. A control of wild type cells yielded no com-
plexes and is not shown.
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expression of tagged proteins inmycobacteria. To construct the expres-
sion vectors, we used three promoter strengths: the strong constitutive
hsp60 promoter, an intermediate synthetic promoter (E. O. Davis,
unpublished), and a titratable anhydrotetracycline-inducible promoter
(Schuessler et al., 2013). We chose to use a combination of either an
N- or C-terminal tandem Strep-tag and a His-tag. The His-tag has the
advantage that it can be used to purify proteins under denaturing con-
ditions, allowing the analysis of interactions with difﬁcult-to-purify
proteins such as those found in the cell wall. We expressed proteins in
an M. smegmatis strain that had been engineered to remove a native
5-His moiety in the GroEL chaperone that has previously interfered
with His-tag puriﬁcation from this species (Noens et al., 2011).
M. smegmatis has the advantage of being easier to handle than the cate-
gory IIIM. tuberculosis. It should be noted that the vectors designed for
these experiments are also functional in M. tuberculosis. Gateway-
adaptation of the vectors allows for quick, cloning-free generation of ex-
pression constructs using a recombination-based approach (Hartley
et al., 2000). Sequence information for the plasmids and plasmid sche-
matics is shown in Figs. 1 and 2.
To validate the system, we used the AceE component of the
pyruvate dehydrogenase complex—a large complex comprised of
three subunits (E1, E2 and E3). In M. tuberculosis, these subunits
are E1:AceE (Rv2241), E2:DlaT (Rv2215) and E3:LpdC (Rv0462). In
M. smegmatis, their homologues are MSMEG_4323, SucB
(MSMEG_4283) and LpdA (MSMEG_0903). The aceE (Rv2241) gene
from M. tuberculosis was ampliﬁed and inserted into pENTR/D/
TOPO (Invitrogen) to construct an entry vector that can be used
with any of the destination vectors described above. The six expres-
sion vectors were transformed into M. smegmatis, with co-
transformation of pBS-Int (Springer et al., 2001) in the case of the
pSIG and pTIG vectors, to provide the integrase gene in trans to facil-
itate chromosomal integration. These vectors lack an integrase gene
to reduce loss of these plasmids once integration into the genome
has taken place.
The construction of the six vectorswas carried out to allow a range of
expression levels to be tested and an N- or C-terminal tag to be used to
achieve optimal expression of the target protein. In the case of AceE, it
was observed that C-terminal tagged versions of the protein are not
well-expressed, and the high expression levels generated from the
hsp60 promoter vectors led to the reduced growth rates of the cells,
making these vectors unsuitable for use in the crosslinking experiments.
Therefore, to test expression from the six vectors in parallel we used as a
control theMtb protein Rv1636,whichwas chosen as its overexpression
has not been shown to be toxic toM. smegmatis and as shown in Fig. 1B
it was successfully expressed from each of the 6 vectors.
To test the effectiveness of in vivo crosslinking with these vectors, a
pTIG-N (AceE) construct, which drives expression of N-terminally
tagged AceE from an anhydrotetracycline-inducible promoter, was cho-
sen. Expression was induced with 100 ng/ml ATc, as this concentration
was well-tolerated by the cells and generated enough protein to allow
puriﬁcation of crosslinked complexes. We optimized the concentration
of formaldehyde and the incubation time required to induce sufﬁcient
crosslinking while minimizing non-speciﬁc complex formation as
described in the Materials and methods section. The complexes were
visualized byWestern blotting for theHis-tag to identify the lowest con-
centration of formaldehyde that led to a shift of the AceE band to a
higher molecular weight, indicating that it was found in complexes
rather than as a monomer, and we settled on 0.4% formaldehyde for
AceE experiments. We suggest that this optimization step is performed
for each protein of interest.
To identify interactions with AceE, we grew 1 liter cultures of the
pTIG-N (AceE) containingM. smegmatis strain and a control strainwith-
out the plasmid in LB + 0.05% Tween 80 for 24 h and formaldehyde
cross-linked protein complexes were puriﬁed from the resulting cell
free extracts by sequential puriﬁcation on StrepTactin and nickel-
Table 1
Identiﬁcation of AceE interactors. LC–MS datawere extracted and ﬁles fromeach band analyzed independently and as a pooled set. Proteins identiﬁedwith at least 2 unique peptideswere
retained.
Accession Gene name Description Unique peptides
Q10504 aceE (Rv2241) M. tuberculosis AceE component (bait) 31
A0R0B0 MSMEG_4323 Pyruvate dehydrogenase E1 component (AceE homologue) 22
A0QQW8 lpdA (MSMEG_0903) Dihydrolipoyl dehydrogenase (LpdC homologue) 5
A0R072 sucB (MSMEG_4283) 2-Oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase (DlaT homologue) 3
A0QTE1 MSMEG_1807 Acetyl-/propionyl-coenzyme A carboxylase alpha chaina 21
A0QS98 Tuf Elongation factor Tu 12
A0QQC8 dnaK Chaperone protein DnaK 9
A4ZHR8 MSMEG1842 Adenosylhomocysteinase 3
A0QTE7 MSMEG_1813 Propionyl-CoA carboxylase beta chaina 2
A0R616 MSMEG_6391 Propionyl-CoA carboxylase beta chaina 2
a Known biotinylated proteins.
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versed by boiling in Laemmli buffer and the proteins separated by
SDS-PAGE. Fig. 3 shows the SDS-PAGE analysis of the eluted proteins.
No proteins were puriﬁed from the control culture (not shown) where-
as a number of bands were co-puriﬁed with AceE. The identity of the
bands following trypsin digestion and LC–MS is shown in Table 1
(Trauner et al., 2011). Of the interactionsdetected, twowere the expect-
ed DlaT and LpdC components of the pyruvate dehydrogenase complex,
indicating that thismethod is capable of accurately detecting protein in-
teractions in mycobacteria. In addition, several proteins not previously
identiﬁed as interacting partners for pyruvate dehydrogenase were
also identiﬁed and it remains to be determined what role these interac-
tions play in vivo. It should, however, be noted that there are a number
of biotinylated proteins in mycobacteria, including some of those co-
puriﬁed with AceE. Biotinylated proteins will bind the StrepTactin
with a high afﬁnity and the possibility of these interactions being false
positives should be considered. Furthermore, the co-puriﬁcation of
highly abundant proteins such as stress proteins or components of the
ribosome may also be due to non-speciﬁc binding. For proteins which
associate with highly promiscuous proteins such as chaperones, it may
be advantageous to narrow down the possible interactors by excluding
the crosslinking step.
We believe that our system for the expression of tagged target pro-
teins in mycobacteria combined with in vivo crosslinking is suitable
for purifying protein complexeswith no or little detectable background.
This method allows for the identiﬁcation of weak or transient interac-
tions while allowing sufﬁcient puriﬁcation of complexes to reduce
false positives. The study of protein interactions in mycobacteria rather
than surrogate hosts such as Escherichia coli has the advantage that the
cellular environment is conducive to real interactions taking place rath-
er than the false positives or false negatives common with other hosts.
The study of large complexes is also difﬁcult in other hosts as interacting
pairs of proteins may need additional factors or proteins to be present
for an interaction to occur. One weakness of this crosslinking approach
that we can anticipate is that the high levels of protein overexpression
under non-native conditions could lead to the identiﬁcation of false pos-
itives. For this reason, we also generated regulatable version of the
vectors to allow expression to be induced at lower levels and under bi-
ologically relevant conditions.
Our system has proven itself to be capable of detecting known pro-
tein interactions and we hope that it will prove useful for the study of
unknown proteins in mycobacteria. Combined with independent
methods of investigating interactions, it will be possible to minimize
false positives and tease apart essential virulence pathways inMtb.
4. Concluding remarks
We have developed Gateway adapted vectors which allow the over-
expression of Strep–Strep–His-tagged proteins from promoters ofdifferent strengths in mycobacteria and show that they are suitable for
use in in vivo crosslinking experiments.
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